Literature DB >> 16792465

Distribution and interrelationship of ubiquitin proteasome pathway component activities and ubiquitin pools in various porcine tissues.

M B Patel1, M Majetschak.   

Abstract

The ubiquitin-proteasome pathway fulfills major biological functions, but its physiologic tissue distribution and the interrelationship between pathway component activities and ubiquitin pools are unknown. Therefore, we analyzed free and conjugated ubiquitin, ubiquitin-protein ligation rates (UbPL) and chymotryptic- and tryptic-like proteasome peptidase activities in porcine skeletal muscle, heart, lung, liver, spleen and kidney (n=5 each). There were considerable differences between tissues (p<0.05 for all parameters). Lung and spleen showed high levels of free and conjugated ubiquitin and high UbPL. Proteasome activities were highest in kidney and heart. There were linear relationships between tryptic-like and chymotryptic-like proteasome peptidase activities (r(2) = 0.624, p<0.001) and between free and conjugated ubiquitin tissue levels (r(2) = 0.623, p<0.001). Tissue levels of free and conjugated ubiquitin correlated linear with UbPL (p<0.005), but they were not correlated with proteasome peptidase activities. The results suggest that tissue ubiquitin pools are tightly regulated and indicate a constant proportion of conjugated ubiquitin. They further support the hypothesis that ubiquitin-protein ligase systems, and probably deubiquitylating enzymes, are key regulators of ubiquitin homeostasis. The detected differences are suggestive of tissue-specific roles of ubiquitin-proteasome pathway components. Besides the known importance of the ubiquitin proteasome pathway in heart, kidney and the immune system, the results suggest the lung as another organ in which ubiquitin proteasome pathway components may also significantly contribute to disease processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16792465

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  20 in total

1.  Ubiquitin is a novel substrate for human insulin-degrading enzyme.

Authors:  Luis A Ralat; Vasilios Kalas; Zhongzhou Zheng; Robert D Goldman; Tobin R Sosnick; Wei-Jen Tang
Journal:  J Mol Biol       Date:  2010-12-23       Impact factor: 5.469

2.  Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells.

Authors:  Rita Crinelli; Marzia Bianchi; Michele Menotta; Elisa Carloni; Elisa Giacomini; Marzia Pennati; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2008-07-09       Impact factor: 3.396

3.  Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation.

Authors:  Nitzan Shabek; Yifat Herman-Bachinsky; Aaron Ciechanover
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

4.  Primary proteasome inhibition results in cardiac dysfunction.

Authors:  Joerg Herrmann; Christine Wohlert; Ardan M Saguner; Ana Flores; Lisa L Nesbitt; Alejandro Chade; Lilach O Lerman; Amir Lerman
Journal:  Eur J Heart Fail       Date:  2013-04-24       Impact factor: 15.534

5.  Circulating 20S proteasome levels in patients with mixed connective tissue disease and systemic lupus erythematosus.

Authors:  Matthias Majetschak; Magdalena Perez; Luis T Sorell; Janet Lam; Marcos E Maldonado; Robert W Hoffman
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

Review 6.  Cardiovascular adverse events in multiple myeloma patients.

Authors:  Markus B Heckmann; Shirin Doroudgar; Hugo A Katus; Lorenz H Lehmann
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 7.  Molecular mechanisms underlying cardiotoxicity of novel cancer therapeutics.

Authors:  Simon Braumann; Stephan Baldus; Roman Pfister
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

8.  Tourniquet-induced ischaemia during total knee arthroplasty results in higher proteolytic activities within vastus medialis cells: a randomized clinical trial.

Authors:  Ahmed Jawhar; Stephan Hermanns; Norbert Ponelies; Udo Obertacke; Henning Roehl
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-11-14       Impact factor: 4.342

9.  A subset of 26S proteasomes is activated at critically low ATP concentrations and contributes to myocardial injury during cold ischemia.

Authors:  Qing Geng; Jacqueline Romero; Vikas Saini; Todd A Baker; Maria M Picken; Richard L Gamelli; Matthias Majetschak
Journal:  Biochem Biophys Res Commun       Date:  2009-12-25       Impact factor: 3.575

Review 10.  The ubiquitin proteasome system in human cardiomyopathies and heart failure.

Authors:  Sharlene M Day
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-11       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.